A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients
NCT ID: NCT00002426
Last Updated: 2005-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
390 participants
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adefovir dipivoxil
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are HIV-positive.
* Have been on a stable HAART regimen consisting of at least 3 antiretroviral drugs for at least 16 weeks prior to study entry.
* Have a CD4 count of 50 cells/mm3 or more.
* Have a viral load greater than 50 and less than or equal to 400 copies/ml within 14 days prior to study entry.
* Have had at least 1 additional viral load in the past that was less than or equal to 400 copies/ml while on your current stable HAART regimen.
0 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gilead Sciences
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pacific Oaks Research
Beverly Hills, California, United States
ViRx Inc
Palm Springs, California, United States
Ctr for AIDS Research / Education and Service (CARES)
Sacramento, California, United States
San Francisco Gen Hosp / UCSF AIDS Program
San Francisco, California, United States
Kaiser Foundation Hospital
San Francisco, California, United States
San Francisco VA Med Ctr
San Francisco, California, United States
Blick Med Associates
Stamford, Connecticut, United States
Georgetown Univ Med Ctr
Washington D.C., District of Columbia, United States
Dupont Circle Physicians Group
Washington D.C., District of Columbia, United States
George Washington Univ Med Ctr
Washington D.C., District of Columbia, United States
IDC Research Initiative
Altamonte Springs, Florida, United States
Community AIDS Resource Inc
Coral Gables, Florida, United States
TheraFirst Med Ctrs Inc
Fort Lauderdale, Florida, United States
Duval County Health Department
Jacksonville, Florida, United States
Health Positive
Safety Harbor, Florida, United States
Center for Quality Care
Tampa, Florida, United States
Georgia Research Associates
Atlanta, Georgia, United States
Rush Presbyterian - Saint Luke's Med Ctr
Chicago, Illinois, United States
Indiana Univ Infectious Disease Research Clinic
Indianapolis, Indiana, United States
Johns Hopkins Univ School of Medicine
Baltimore, Maryland, United States
Albany Med College
Albany, New York, United States
Bentley-Salick Med Practice
New York, New York, United States
St Luke Roosevelt Hosp
New York, New York, United States
James Jones MD
New York, New York, United States
Mount Sinai Med Ctr
New York, New York, United States
Wake Forest Univ School of Medicine
Winston-Salem, North Carolina, United States
Associates of Med and Mental Health
Tulsa, Oklahoma, United States
The Research and Education Group
Portland, Oregon, United States
Miriam Hosp
Providence, Rhode Island, United States
Roger Williams Med Ctr
Providence, Rhode Island, United States
Vanderbilt Univ School of Medicine
Nashville, Tennessee, United States
Univ of Texas Southwestern Med Ctr of Dallas
Dallas, Texas, United States
Univ of Texas Med Branch
Galveston, Texas, United States
Thomas Street Clinic
Houston, Texas, United States
Univ of Utah Med School / Clinical Trials Ctr
Salt Lake City, Utah, United States
Infectious Disease Physicians Inc
Annandale, Virginia, United States
N Touch Research Corp
Seattle, Washington, United States
St Paul's Hosp
Vancouver, British Columbia, Canada
Sunnybrook Health Science Centre
Toronto, Ontario, Canada
Centre hospitalier de l'Universite de Montreal (CHUM)
Montreal, Quebec, Canada
Hopital Edouard Herriot
Lyon, , France
Hopital Sainte-Marguerite
Marseille, , France
Klinikum Der Johann Wolfgang Goethe Universitat
Frankfurt, , Germany
Universitatskrankenhaus Eppendorf
Hamburg, , Germany
Klinikum der Ludwig-Maximilians-Universitaet
München, , Germany
Chelsea and Westminster Hosp
London, , United Kingdom
King's College Hospital
London, , United Kingdom
Royal Free Hosp
London, , United Kingdom
Senior Lecturer in GU Medicine
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GS-97-415
Identifier Type: -
Identifier Source: secondary_id
232K
Identifier Type: -
Identifier Source: org_study_id